Cargando…
Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury
Cancer treatment-induced toxicities may restrict maximal effective dosing for treatment and cancer survivors’ quality of life. It is critical to develop novel strategies that mitigate treatment-induced toxicity without affecting the efficacy of anti-cancer therapies. Rapamycin is a macrolide with an...
Autores principales: | Zhou, Qingyu, Doherty, Justin, Akk, Antonina, Springer, Luke E., Fan, Ping, Spasojevic, Ivan, Halade, Ganesh V., Yang, Huanghe, Pham, Christine T. N., Wickline, Samuel A., Pan, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839776/ https://www.ncbi.nlm.nih.gov/pubmed/35159680 http://dx.doi.org/10.3390/nano12030336 |
Ejemplares similares
-
Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury
por: Zhou, Qingyu, et al.
Publicado: (2023) -
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics
por: Tran, Trung D, et al.
Publicado: (2007) -
Induction of WNT16 via Peptide-mRNA Nanoparticle-Based Delivery Maintains Cartilage Homeostasis
por: Yan, Huimin, et al.
Publicado: (2020) -
Neutrophil Extracellular Traps Enhance Early Inflammatory Response in Sendai Virus-Induced Asthma Phenotype
por: Akk, Antonina, et al.
Publicado: (2016) -
Dual PARACEST and (19)F MR molecular imaging of fibrin clots with targeted perfluorocarbon nanoparticles
por: Cai, Kejia, et al.
Publicado: (2009)